| Active substance |
Chlorthalidone |
| Also known as |
Chlortalidone |
| Blood pressure |
Lowers blood pressure |
| Chemical name |
2-Chloro-5-(1-hydroxy-3-oxo-1-isoindolinyl)benzenesulfonamide |
| Dosage (medical) |
Commonly 12.5 mg to 25 mg daily for hypertension |
| Dosage (sports) |
Not applicable for sports enhancement |
| Effects |
Reduces blood pressure, decreases fluid retention |
| Formula |
C14H11ClN2O4S |
| Half-life |
Approximately 40 to 60 hours |
| Hepatotoxicity |
Minimal risk |
| Lab Test |
Can affect electrolyte and glucose levels |
| Main action |
Diuresis and antihypertensive |
| Side effects |
Dizziness, dehydration, hypokalemia, hyperglycemia, increased uric acid |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
12.5mg |
| Substance class |
Thiazide-like diuretic |
| Trade name |
Hygroton, Thalitone |
| Use in sports |
Not typically used in sports, potential for misuse in weight class sports for rapid weight loss |
| Water Retention |
Reduces water retention |
| Manufacturer |
Ipca Laboratories Ltd |
| Packing |
15 tabs/blister |
